207 related articles for article (PubMed ID: 77412)
1. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
Bateson MC; Ross PE; Murison J; Bouchier IA
Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
[TBL] [Abstract][Full Text] [Related]
2. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
Bateson MC; Hill A; Bouchier IA
Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
[TBL] [Abstract][Full Text] [Related]
3. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
Iser JH; Dowling H; Mok HY; Bell GD
N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
[TBL] [Abstract][Full Text] [Related]
4. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
Grundy SM; Lan SP; Lachin J
J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
[TBL] [Abstract][Full Text] [Related]
5. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
Iser JH; Maton PN; Murphy GM; Dowling RH
Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
7. Increase in serum total cholesterol and low-density lipoprotein cholesterol by high-dose chenodeoxycholic acid in patients with radiolucent gallstones significantly reversed during preventive low dose after gallstone dissolution.
Pérez-Aguilar F; Bretó M; Alegre B; Berenguer J
Digestion; 1985; 31(4):225-33. PubMed ID: 4007294
[TBL] [Abstract][Full Text] [Related]
8. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.
Barbara L; Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R
Digestion; 1976; 14(3):209-19. PubMed ID: 955328
[TBL] [Abstract][Full Text] [Related]
9. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
11. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
Iwamura K
Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
[TBL] [Abstract][Full Text] [Related]
13. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a monitored dose with a standard dose of chenodeoxycholic acid for gallstone dissolution.
Whiting MJ; Bradley BM; Hall JC; Watts JM
Digestion; 1984; 30(4):211-7. PubMed ID: 6510572
[TBL] [Abstract][Full Text] [Related]
15. Oral dissolution therapy for cholelithiasis: mix and match.
Phillips RS; Barkin JS
Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
[TBL] [Abstract][Full Text] [Related]
16. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
[TBL] [Abstract][Full Text] [Related]
17. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
18. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
19. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
Petroni ML; Jazrawi RP; Pazzi P; Lanzini A; Zuin M; Pigozzi MG; Fracchia M; Galatola G; Alvisi V; Heaton KW; Podda M; Northfield TC
Aliment Pharmacol Ther; 2001 Jan; 15(1):123-8. PubMed ID: 11136285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
